First Trust Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
First Trust Advisors's IOVA Position: Q3 2026 in Review
First Trust Advisors opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 649,127 shares worth $9.6M. The stake represents 0.01% of the portfolio and ranks #1224 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in IOVA as recently as Q1 2025.
First Trust Advisors first reported a position in IOVA in Q4 2024 and has held it in 3 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- First Trust Advisors held 649,127 shares of Iovance Biotherapeutics worth $9.6M as of Q3 2026.
- Iovance Biotherapeutics was a new First Trust Advisors position in Q3 2026.
- Iovance Biotherapeutics made up 0.01% of First Trust Advisors's portfolio in Q3 2026, its #1224 holding.
- First Trust Advisors first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 3 quarters since.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.